Teva Fends Off Peers In Bendeka Legal Victory

Defeats Challengers Apotex, Fresenius Kabi, Mylan And Slayback

 
• By Dave Wallace

Teva has fought off US challenges from several of its generics peers over US patents protecting the Bendeka brand that the Israeli firm licenses from Eagle Pharmaceuticals.

Lawsuit
Teva’s legal victory saw it beat off challenges from four other generics firms • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin